Imipramine Hydrochloride

• Clinical trial to evaluate the effectiveness and efficiency of a pre-emptive pharmacogenetic strategy for antidepressant selection in patien… Pending
  2025-522967-13-00 Phase IV 1 country Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz
• A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for major depressive disorder c… Recruiting
  2023-506617-21-00 Phase III 5 countries Universitair Medisch Centrum Utrecht
• HIsTological and CLinical effects of Imipramine in the treatment of patients with cancer over-expressing Fascin1. (HITCLIF) Recruiting
  2023-504943-15-00 Phase II 1 country Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
• Efficacy and Tolerability of AP707 in Patients with chronic Pain due to Diabetic Polyneuropathy Ended
  2022-500897-32-00 Phase III 2 countries Apurano Pharmaceuticals GmbH; Cannaxan GmbH
• Efficacy and Tolerability of AP707 in Patients with chronic Pain due to traumatic or post-operative peripheral Neuropathy Ended
  2022-500898-13-00 Phase III 2 countries Apurano Pharmaceuticals GmbH; Cannaxan GmbH
• Efficacy and Tolerability of AP707 in Patients with chronic pain due to central Neuropathy of any Genesis Ended
  2022-500899-66-00 Phase III 2 countries Apurano Pharmaceuticals GmbH; Cannaxan GmbH
• Efficacy and Tolerability of AP707 in Patients with Chronic Back Pain Ended
  2022-502151-54-00 Phase III 2 countries Apurano Pharmaceuticals GmbH; Cannaxan GmbH

Showing 1–7 of 7 trials